Medicare Enrolled
Dr. Maria Rumsey, MD
Cardiovascular Disease · Dartmouth, MA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rumsey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rumsey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rumsey
Dr. Maria Rumsey is a cardiovascular disease specialist in Dartmouth, MA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Rumsey performed 3,771 Medicare services across 2,178 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rumsey received a total of $46,173 from 41 pharmaceutical and/or device companies across 791 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rumsey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 18% volume in MA
$46,173 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,771
Medicare services
Top 18% in MA for cardiovascular disease
2,178
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~210 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
385 | $30 | $120 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
350 | $127 | $467 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
340 | $11 | $118 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
267 | $37 | $162 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
225 | $37 | $206 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
224 | $58 | $248 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
223 | $6 | $38 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
182 | $51 | $173 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
163 | $138 | $690 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
110 | $18 | $85 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
98 | $16 | $84 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
80 | $48 | $192 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
76 | $93 | $324 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
73 | $8 | $17 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
73 | $19 | $84 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
73 | $136 | $627 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
72 | $19 | $98 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
69 | $96 | $335 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $91 | $343 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
55 | $4 | $30 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
45 | $16 | $560 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
42 | $50 | $235 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
41 | $366 | $1,526 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
41 | $54 | $164 |
| New patient office visit, complex (60-74 min) | 39 | $153 | $648 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
33 | $82 | $359 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
28 | $17 | $120 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
28 | $11 | $100 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
27 | $35 | $136 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
27 | $24 | $142 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
26 | $10 | $37 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $130 | $510 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
25 | $2 | $12 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
23 | $81 | $339 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $66 | $308 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
22 | $86 | $369 |
| Direct bilirubin level test A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver. |
16 | $5 | $17 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
16 | $14 | $67 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
14 | $20 | $88 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
13 | $64 | $226 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
11 | $13 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.1% high complexity
9.7% medium
79.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$46,173
Total received (2018-2024)
Avg $6,596/year across 7 years
Top 11% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
791
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25,615 (55.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,975 (38.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,583 (5.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$18,061
2023
$11,678
2022
$3,162
2021
$3,283
2020
$2,070
2019
$3,740
2018
$4,179
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$12,330
Lilly USA, LLC
$3,740
Abbott Laboratories
$344
PFIZER INC.
$219
Kiniksa Pharmaceuticals International, plc
$197
E.R. Squibb & Sons, L.L.C.
$174
Novartis Pharmaceuticals Corporation
$135
AstraZeneca Pharmaceuticals LP
$134
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$129
Amgen Inc.
$120
Boston Scientific Corporation
$118
Janssen Pharmaceuticals, Inc
$114
Actelion Pharmaceuticals US, Inc.
$110
Novo Nordisk Inc
$76
Merck Sharp & Dohme LLC
$53
Baxter Healthcare
$31
Bayer Healthcare Pharmaceuticals Inc.
$22
Esperion Therapeutics, Inc.
$15
Top 3 companies account for 90.9% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$21,030
E.R. Squibb & Sons, L.L.C.
$4,719
Lilly USA, LLC
$4,510
Boston Scientific Corporation
$3,533
Abbott Laboratories
$1,519
Cardiologs Technologies
$1,250
Janssen Pharmaceuticals, Inc
$1,180
Amgen Inc.
$1,173
Novartis Pharmaceuticals Corporation
$1,166
PFIZER INC.
$592
AstraZeneca Pharmaceuticals LP
$582
Edwards Lifesciences Corporation
$489
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$417
Kowa Pharmaceuticals America, Inc.
$384
Novo Nordisk Inc
$357
Alnylam Pharmaceuticals Inc.
$259
Gilead Sciences, Inc.
$228
BIOTRONIK INC.
$223
Regeneron Healthcare Solutions, Inc.
$206
Medtronic Vascular, Inc.
$201
Kiniksa Pharmaceuticals International, plc
$197
AtriCure, Inc.
$185
Amarin Pharma Inc.
$163
Bardy Diagnostics, Inc.
$154
Astellas Pharma US Inc
$147
BOSTON SCIENTIFIC CORPORATION
$144
Inari Medical, Inc.
$140
SANOFI-AVENTIS U.S. LLC
$124
Relypsa, Inc.
$118
Actelion Pharmaceuticals US, Inc.
$110
Bayer Healthcare Pharmaceuticals Inc.
$106
Medtronic, Inc.
$102
Merck Sharp & Dohme LLC
$102
Lantheus Medical Imaging, Inc.
$94
SCPHARMACEUTICALS INC.
$71
Esperion Therapeutics, Inc.
$53
Kiniksa Pharmaceuticals, Ltd.
$43
Baxter Healthcare
$31
Bayer HealthCare Pharmaceuticals Inc.
$29
Lexicon Pharmaceuticals, Inc.
$25
AngioDynamics, Inc.
$17
Top 3 companies account for 65.5% of all-time payments
Associated products mentioned in payments ›
ALPHAVAC · AMPLATZER AMULET · AMPLATZER Occluders · AZURE XT DR MRI SURESCAN · Arcalyst · Assurity Pacemaker · BRILINTA · CAMZYOS · CARDIOMEMS · Cardiologs Platform · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · DEFINITY · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL BRADY · GENERAL THERAPIES · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL BRADY · GENERAL THERAPIES · General - Therapies · Hillrom - Cardiac Ambulatory Monitor · Inpefa · JARDIANCE · Kerendia · LATITUDE · LEQVIO · LEXISCAN · LUX DX · LUX-DX · LifeVest · Livalo · MICRA · Micra · MyCareLink · MyCareLink Smart · NEXLETOL · ONPATTRO · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · REVEAL LINQ · Repatha · Reveal LINQ · S · SQ-RX PULSE GENERATOR · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Cardiologists within 10 mi
119
Per 100K population
20.6
County median income
$84,198
Nearest hospital
SOUTHCOAST BEHAVIORAL HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rumsey is a remote & electrophysiology specialist, with above-average Medicare volume (top 18% in MA), with speaking/promotional industry engagement in the top 11% of MA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rumsey experienced with remote vital sign monitoring management, each additional 20 minutes?
Based on Medicare claims data, Dr. Rumsey performed 385 remote vital sign monitoring management, each additional 20 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rumsey receive payments from pharmaceutical companies?
Yes. Dr. Rumsey received a total of $46,173 from 41 companies across 791 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rumsey's costs compare to other cardiologists in Dartmouth?
Dr. Rumsey's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rumsey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Dartmouth
Browse cardiologists in Dartmouth ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology